Flunixin meglumine
SIGMA/F0429 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 42461-84-7
Empirical Formula (Hill Notation): C14H11F3N2O2·C7H17NO5
Molecular Weight: 491.46
EC Number: 255-836-0
MDL Number: MFCD01725419
Linear Formula: C14H11F3N2O2·C7H17NO5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C14H11F3N2O2.C7H17NO5/ |
| InChI key | MGCCHNLNRBULBU-WZTVWXICSA |
| mp | 136.6-137.4 °C |
| Quality Level | 100 ![]() |
| SMILES string | CNC[C@H](O)[C@@H](O)[C@H] |
| solubility | H2O: freely soluble |
| storage temp. | room temp |
| Application: | Flunixin meglumine (IC50 = 1 nM) can be used as a drug for animals for the management of intestinal ischaemia, colic, and endotoxemia in horses. |
| Application: | Flunixin meglumine has been used as a nonsteroidal anti-inflammatory drug standard in electrospray ionization mass spectrometry (LC-ESI/MS). |
| Biochem/physiol Actions: | COX1, COX2 and PLA2 inhibitor non-narcotic analgesic, anti-pyretic, anti-inflammatory. |
| Biochem/physiol Actions: | Flunixin meglumine is a nonsteroidal anti-inflammatory drug, which blocks prostaglandin synthesis. |
| Packaging: | 100, 500 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H315 - H319 - H335 |
| Precautionary statements | P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥98% (HPLC) |
| mp | 136.6-137.4 °C |
| Storage Temp. | room temp |
| UNSPSC | 12352200 |


